The challenges for oncology market access are expected to increase and grow in the near future, making Oncology Market Access Europe – Payer and Industry Perspectives a must-read report not only for those working in market access, brand strategy, business development and licensing, but in biosimilars, payer relationships and drug innovation. Report available for purchase here. (Source: FirstWord, July 2014).